home / stock / cntb / cntb quote
Last: | $1.27 |
---|---|
Change Percent: | 1.19% |
Open: | $1.245 |
Close: | $1.27 |
High: | $1.3 |
Low: | $1.13 |
Volume: | 24,026 |
Last Trade Date Time: | 09/10/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.27 | $1.245 | $1.27 | $1.3 | $1.13 | 24,026 | 09-10-2024 |
$1.26 | $1.3 | $1.26 | $1.3 | $1.1501 | 24,386 | 09-09-2024 |
$1.25 | $1.09 | $1.25 | $1.25 | $1.09 | 36,527 | 09-06-2024 |
$1.1899 | $1.27 | $1.1899 | $1.34 | $1.13 | 37,594 | 09-05-2024 |
$1.29 | $1.24 | $1.29 | $1.3 | $1.24 | 32,506 | 09-04-2024 |
$1.285 | $1.6 | $1.285 | $1.6 | $1.285 | 41,264 | 09-03-2024 |
$1.6 | $1.38 | $1.6 | $1.6 | $1.2 | 217,202 | 09-02-2024 |
$1.6 | $1.38 | $1.6 | $1.6 | $1.2 | 217,202 | 08-30-2024 |
$1.28 | $1.0141 | $1.28 | $1.38 | $1 | 166,554 | 08-29-2024 |
$0.994 | $1 | $0.994 | $1.09 | $0.994 | 5,012 | 08-28-2024 |
$1.0015 | $1.075 | $1.0015 | $1.1 | $1.0015 | 7,116 | 08-27-2024 |
$1.02 | $1 | $1.02 | $1.03 | $1 | 3,886 | 08-26-2024 |
$1.0221 | $1.02 | $1.0221 | $1.0403 | $1 | 16,616 | 08-23-2024 |
$1.01 | $1.04 | $1.01 | $1.05 | $1.01 | 30,423 | 08-22-2024 |
$1.045 | $1.12 | $1.045 | $1.12 | $1.03 | 68,788 | 08-21-2024 |
$1.05 | $1.11 | $1.05 | $1.13 | $1.05 | 32,491 | 08-20-2024 |
$1.14 | $1.1317 | $1.14 | $1.1417 | $1.1301 | 4,511 | 08-19-2024 |
$1.11 | $1.19 | $1.11 | $1.19 | $1.1043 | 35,280 | 08-16-2024 |
$1.18 | $1.175 | $1.18 | $1.2093 | $1.14 | 3,276 | 08-15-2024 |
$1.17 | $1.19 | $1.17 | $1.19 | $1.0918 | 13,004 | 08-14-2024 |
News, Short Squeeze, Breakout and More Instantly...
Connect Biopharma Holdings Limited Company Name:
CNTB Stock Symbol:
NASDAQ Market:
Connect Biopharma Holdings Limited Website:
SAN DIEGO, CA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma,” “Connect” or the “Company”), a U.S.-headquartered global clinical-stage biopharmaceutical company dedicated to improving the lives of...
Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer (CEO) and David Szekeres as President Connect’s new management is currently evaluating the future clinical development strategy for rademikibart As part of Connect’s ...
A look at the top 10 most actives in the United States Nu Holdings Ltd. Class A (NU) rose 5.2% to $14.97 on volume of 557,476,210 shares UTime Limited (WTO) fell 16.6% to $0.0756 on volume of 370,923,634 shares NVIDIA Corporation (NVDA) rose 1.5% to $119.37 on volume of 331,427,665 shares ...